世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

合成生物学グローバル市場


Synthetic Biology: Global Markets

報告書の範囲 本調査の対象は、2026年までに既に商業化されているか、商業化が予測されている合成生物学の中核製品(オリゴヌクレオチド、合成遺伝子、バイオブリック部品、送達プラスミド、シャーシ生物、合... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
BCC Research
BCCリサーチ
2022年2月18日 US$5,500
シングルユーザライセンス(印刷不可)
ライセンス・価格情報
注文方法はこちら
344 英語

 

サマリー

報告書の範囲

本調査の対象は、2026年までに既に商業化されているか、商業化が予測されている合成生物学の中核製品(オリゴヌクレオチド、合成遺伝子、バイオブリック部品、送達プラスミド、シャーシ生物、合成細胞、セルベースおよび無細胞生産システムなど)、実現技術(DNA配列決定、DNA合成、遺伝子編集、バイオインフォーマティクス、特殊メディアなど)および実現技術(ヘルスケア、工業化学、消費財、飲食、農業など)である。

主要な合成生物学の技術および製品を分析し、市場の現状と将来、および2021年から2026年までの成長予測を明らかにします。また、戦略的提携、産業構造、競争力学、特許、市場牽引力に関する詳細な考察も行っています。

BCCリサーチは合成生物学産業を、DNA配列決定、DNA合成、遺伝子編集、合成生物学ファウンドリ、ソフトウェアなどの市場セグメントや、農業、消費者製品、化粧品とスキンケア、食品と飲料、ヘルスケア、工業薬品を可能にする製品分野別に調査しています。

2018年から2020年にかけての主要な戦略的提携と買収の役割について考察しています。合成遺伝子、合成生物学に基づく医薬品とワクチン、ゲノム編集作物とシャーシ生物、および合成燃料と特殊化学品を生産するための代謝工学的工場などの新興市場を分析し、これらの分野の215社以上を取り上げています。

レポートには、以下の内容が含まれます。

- データ表30枚、付表99枚
- ライフサイエンス産業における合成生物学の世界市場に関する最新のレビューと分析
- 2019年から2021年までのデータを用いた世界市場動向の分析、および2026年までの年平均成長率(CAGR)の予測
- 合成生物学の世界市場規模、成長トレンド予測、製品タイプ・エンドユーザー産業・地域別に対応する市場シェア分析などの評価・予測
- 合成生物学製品および技術に関する現在および将来の市場可能性のハイライトと、この市場を様々なセグメントおよびサブセグメントに分けて予測するための注目点
- 合成生物学の中核製品、主要な実現技術の説明、製品開発のための商機と競争戦略の特定
- 合成生物学の産業構造、競合他社のレビュー、知的財産の状況についての詳細な評価
- 合成生物学業界のM&A案件、実用化可能な製品・技術の開発、その他業界内の戦略的提携に関する情報を提供します。
- 合成生物学技術、リキッドバイオプシーとシーケンシング、遺伝子編集産業に関する特許のレビューと取得済み特許の分析
- 合成生物学業界の約185社以上の企業の詳細なプロフィールを掲載しています。主要企業は、Agilent Technologies Inc.、Eurofins Scientific、GenScript、Merck KGaA、Novozymes A/S、Thermo Fisher Scientific Inc、およびTwist Bioscienceなどです。

ページTOPに戻る


目次

Table of Contents
Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing the Study
Contribution of the Study and for Whom
What's New in This Update?
Scope and Format
Methodology
Information Sources
Geographical Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
Chapter 2 Summary and Highlights
Chapter 3 Overview
Synthetic Biology Technologies Covered in this Report
Value Chain Analysis
Synthetic Biology Overview
Development Stage of Synthetic Biology
Forces Driving the Growth of the Market for Synthetic Biology
Global Market for Synthetic Biology by End-User Industry
Product and Technology Life Cycles
Synthetic Biology Industry
Impact of COVID-19 on the Global Market for Synthetic Biology
Chapter 4 Technology Background
Introduction
Synthetic Biology Defined
Synthetic Biology History
Unique Commercially Available Synthetic Biology Products
Leghemoglobin
Sitgaliptin
Hyaline
PROVEN, a Biological Nitrogen Fertilizer for Corn by Pivot Bio
Kymriah
Calyno
Paradigm Shift in Biology
Synthetic Biology Technology Overview
Enabling Technologies
DNA-Synthesis and DNA-Sequencing Cost Trends
DNA-Synthesis Technologies
Microfluidic Technologies
Next-Generation Sequencing Technologies
Gene Editing
Gene Drives
Bioinformatics Technologies
Biologic Components and Integrated Systems Technologies
Synthetic DNA
BioBrick Parts
Minimal Genomes and Chassis Organisms
Enabled Products
Pathway Engineering
Research and Development Applications
Synthetic Biology and the Microbiome
Synthetic Biology in Biofuels Feedstocks
Synthetic Biology Microbiome Initiatives
Current Governance and Regulations
U.S. Regulations
International Regulations
Chapter 5 Synthetic Biology Applications
Enabling Technologies Applications
Biologic Components and Integrated Systems Applications
Synthetic Genes
BioBrick Parts
Integrated Systems
Enabled Products Applications
Pharmaceuticals
Industrial Biotechnology Applications
Agricultural Applications
Data Storage Applications
Chapter 6 Synthetic Biology Industry
Investment in Synthetic Biology Industry
Industrial Biotechnology Value Chain
Industry Structural Forces
Products and Technology Life Cycle
Sequencing Instruments Industry
Long-Read Sequencing Industry
DNA Synthesis Industry
Oligos as Therapeutics
Gene Synthesis Workflow
Gene Synthesis Value Chain
Synthetic Gene Market Segments
Gene-Editing Industry
Synthetic Biology Organism Design and Foundries Industry
Software Industry
Agriculture Industry
Consumer Products Industry
Cosmetics and Skin Care Industry
Food and Beverage Industry
Healthcare Industry
Industrial Chemicals Industry
Cell-Free System Industry
Industry Acquisitions and Strategic Alliances
Chapter 7 Global Market for Synthetic Biology
Industry Growth-Driving Forces
DNA Read, Write and Edit Technologies
Growing Role of Designer Organisms
Speeding up of Commercialization Pathways
Growth in Synthetic Biology Foundries
Increasing Research and Development Investment by Pharma Companies
Global Market for Synthetic Biology by End-User Industry
Research Market
Healthcare Market
Industrial Chemicals Market
Agriculture Market
Consumer Market
Food and Beverage Market
Global Market for Synthetic Biology by Product Type
Enabling Products Market
Synthetic Biologic Components Market
Integrated Systems Market
Enabled Products Market
Geographic Markets
Synthetic Biology Products by Region
Enabling Products Market by Region
Core Products Market by Region
Enabled Products Market by Region
Chapter 8 Patents
Introduction
Foundational Patents
Synthetic Biology Patent Analysis
Sequencing-Related Patent Issues
Gene Editing-Related Patents
Gene Editing Patents: Sangamo Case Study
Chapter 9 Company Profiles
Key Market Players
AGILENT TECHNOLOGIES INC.
AMYRIS INC.
CODEXIS INC.
EUROFINS SCIENTIFIC
GENSCRIPT
GINKGO BIOWORKS
MERCK KGAA
NOVOZYMES A/S
THERMO FISHER SCIENTIFIC INC.
TWIST BIOSCIENCE
VIRIDOS
Other Players
20N LABS INC.
ABEONA THERAPEUTICS LLC
ACTIVE MOTIF
AEMETIS INC.
AGRIVIDA INC.
AJINOMOTO CO., INC.
ALGENUITY
AMBRX INC.
AMFORA INC.
ANSA BIOTECHNOLOGIES INC.
ANTHEIA INC.
ARBOR BIOTECHNOLOGIES INC.
ARCADIA BIOSCIENCES INC.
ARCTURUS THERAPEUTICS INC.
ARDRA BIO INC.
ARZEDA CORP.
ASTRAZENECA PLC
ATG BIOSYNTHETICS GMBH
ATUM
AVECIA
AZARGEN BIOTECHNOLOGIES PTY., LTD.
AZITRA INC.
BASF AG
BAYER AG
BEAM THERAPEUTICS INC.
BENCHLING
BENSON HILL BIOSYSTEMS INC.
BIO BASIC INC.
BIOGEN INC.
BIOMAX INFORMATICS AG
BIOMX LTD.
BIONEER CORP.
BIO S&T INC.
BIOSYNTIA APS
BLUEBIRD BIO INC.
BOLT THREADS INC.
BRISTOL-MYERS SQUIBB CO.
CALYSTA INC.
CALYXT INC.
CARGILL INC.
CARIBOU BIOSCIENCES INC.
CRISPR THERAPEUTICS
CASZYME
CATALOG TECHNOLOGIES, INC.
CELLECTIS SA
CENTRIENT PHARMACEUTICALS
CHAIN BIOTECHNOLOGY LTD.
CIBUS INC.
C-LECTA GMBH
CODAGENIX INC.
COLORIFIX LTD.
CORBION
CRONOS GROUP
CROWN LABORATORIES INC.
DANAHER CORP.
DEMURIS LTD.
DNA SCRIPT
DOVETAIL GENOMICS LLC
DOWDUPONT INC.
EDIGENE INC.
EDITAS MEDICINE INC.
ELIGO BIOSCIENCE SAS
ENDLESS WEST
ENEVOLV INC.
EPOCH LIFE SCIENCE INC.
EVONETIX
EVOLVA SA
EXXONMOBIL CORP.
G+FLAS LIFE SCIENCES INC.
GEA ENZYMES
GELTOR INC.
GENEMED SYNTHESIS INC.
GENERAY BIOTECH CO., LTD.
GENOMATICA
GENUS PLC
GEVO INC.
GILEAD SCIENCES INC.
GLAXOSMITHKLINE PLC
GLOBAL BIOENERGIES
GLOWEE- UNREASONABLE GROUP
GLYCOSBIO FOOD SCIENCES
GLYCOSYN LLC
GOODYEAR TIRE & RUBBER CO.
HELIXWORKS TECHNOLOGIES LTD.
HOMOLOGY MEDICINES INC.
HORIZON DISCOVERY GROUP PLC
HUVEPHARMA
ILLUMINA INC.
IMPOSSIBLE FOODS INC.
INDUSTRIAL MICROBES INC.
INGENZA LTD.
INOVIO PHARMACEUTICALS INC.
INSCRIPTA INC.
INTELLIA THERAPEUTICS INC.
INTERNATIONAL BUSINESS MACHINES
JOYN BIO
KANEKA CORP.
KWS SAAT SE
LABGENIUS LTD.
LANZATECH
LATTICE AUTOMATION INC.
LC SCIENCES
LCY CHEMICAL CORP.
LGC GROUP
LOCUS BIOSCIENCES
LOGICBIO THERAPEUTICS
LUMEN BIOSCIENCE
LYGOS INC.
MEISSA VACCINES, INC.
MICROSYNBIOTIX
MICROBYRE, INC.
MICROSOFT CORP.
MILIS BIO LTD.
MODERN MEADOW
MODULAR GENETICS INC.
MOLECULAR ASSEMBLIES INC.
MORPHOSYS AG
MOTIF INGREDIENTS
NEW ENGLAND BIOLABS
NOVARTIS PHARMA AG
NOVOME BIOTECHNOLOGIES INC.
NOVVI LLC
NUCELIS LLC
NUCLERA NUCLEICS LTD.
OMEGA BIO-TEK INC.
ORAGENICS INC.
OXFORD BIOMEDICA PLC
PAIRWISE PLANTS INC.
PFIZER INC.
PHIO PHARMACEUTICALS CORP.
PHYTOWELT GREEN TECHNOLOGIES GMBH
PIVOT BIO
POSEIDA THERAPEUTICS INC.
PRECISION BIOSCIENCES INC.
PROKARIUM HOLDINGS LTD.
PROMEGA CORP.
PTC THERAPEUTICS INC.
RECOMBINETICS INC.
ROQUETTE FRERES
ROYAL DSM NV
SANGAMO THERAPEUTICS INC.
SAREPTA THERAPEUTICS INC.
SCARAB GENOMICS LLC
SENTI BIOSCIENCES
SHINEGENE MOLECULAR BIO-TECHNOLOGIES INC.
SIGMA ALDRICH CORP.
SHERLOCK BIOSCIENCES
SILICOLIFE LDA.
SOCATI CORP.
SPIBER INC.
STRING BIO
SUGARLOGIX
SYNBIO TECHNOLOGIES INC.
SYNGENTA AG (CHEMCHINA)
SYNTHEGO CORP.
SYNLOGIC THERAPEUTICS
SYNTHACE LTD.
SYNTHETIC BIOLOGICS INC.
TAKARA BIO
TEPHA INC.
TESELAGEN BIOTECHNOLOGY INC.
TIERRA BIOSCIENCES
TOOLGEN
TRANSCRIPTIC INC.
TROPIC BIOSCIENCES U.K. LTD.
TRITON ALGAE INNOVATIONS LTD.
VEDANTA BIOSCIENCES
VERSALIS SPA
VERTEX PHARMACEUTICALS INC.
VIR BIOTECHNOLOGY INC.
XYPHOS BIOSCIENCES, INC.
YIELD10 BIOSCIENCES INC.
ZIOPHARM ONCOLOGY, INC.
ZYMERGEN
ZYMOCHEM INC.

 

ページTOPに戻る


 

Summary

Report Scope:

The study scope includes core synthetic biology products (e.g., oligonucleotides, synthetic genes, BioBrick parts, delivery plasmids, chassis organisms, synthetic cells, cell-based and cell-free production systems), enabling technologies (e.g., DNA sequencing, DNA synthesis, gene editing, bioinformatics, specialty media) and enabled technologies (e.g., healthcare, industrial chemicals, consumer products, food and beverage, agriculture) that are already commercialized or are forecast to be commercialized through 2026.

Key synthetic biology technologies and products are analyzed to determine present and future market status, as well as forecasted growth from 2021 to 2026. An in-depth discussion of strategic alliances, industry structures, competitive dynamics, patents and market-driving forces is also provided.

BCC Research examines the synthetic biology industry by market segment, including DNA sequencing, DNA synthesis, gene editing, synthetic biology foundries and software; as well as the agriculture; consumer products, cosmetics and skin care, food and beverage, healthcare and industrial chemicals enable product sectors.

The role of key strategic alliances and acquisitions from 2018 to 2020 is discussed. Emerging markets, including synthetic genes, synthetic-biology-enabled drugs and vaccines, genome-edited crops and chassis organisms; as well as metabolically engineered factories for producing synthetic fuels and specialty chemicals, are analyzed, and more than 215 companies in these fields are highlighted.

Report Includes:

- 30 data tables and 99 additional tables
- An up-to-date review and analysis of the global market for synthetic biology within the life science industry
- Analyses of the global market trends, with data from 2019 to 2021, and projections of compound annual growth rates (CAGRs) through 2026
- Evaluation and forecast the global synthetic biology market size, forecasted growth trends, and corresponding market share analysis by product type, end-user industry, and region
- Highlights of the current and future market potential for synthetic biology products and technologies, and areas of focus to forecast this market into various segments and sub-segments
- Description of core synthetic biology products, key enabling technologies, and identify commercial opportunities for product development and competitive strategies
- In-depth assessment of the synthetic biology industry structure, competitors review, and intellectual property landscape
- Information on synthetic biology industry M&A deals, development of commercially viable products and technologies, and other strategic alliances within the industry
- Patent review and analysis of patents granted for synthetic biology technologies, liquid biopsy and sequencing, and gene-editing industry
- Detailed profiles of about 185+ companies within synthetic biology industry. Major players include Agilent Technologies Inc., Eurofins Scientific, GenScript, Merck KGaA, Novozymes A/S, Thermo Fisher Scientific Inc., and Twist Bioscience



ページTOPに戻る


Table of Contents

Table of Contents
Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing the Study
Contribution of the Study and for Whom
What's New in This Update?
Scope and Format
Methodology
Information Sources
Geographical Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
Chapter 2 Summary and Highlights
Chapter 3 Overview
Synthetic Biology Technologies Covered in this Report
Value Chain Analysis
Synthetic Biology Overview
Development Stage of Synthetic Biology
Forces Driving the Growth of the Market for Synthetic Biology
Global Market for Synthetic Biology by End-User Industry
Product and Technology Life Cycles
Synthetic Biology Industry
Impact of COVID-19 on the Global Market for Synthetic Biology
Chapter 4 Technology Background
Introduction
Synthetic Biology Defined
Synthetic Biology History
Unique Commercially Available Synthetic Biology Products
Leghemoglobin
Sitgaliptin
Hyaline
PROVEN, a Biological Nitrogen Fertilizer for Corn by Pivot Bio
Kymriah
Calyno
Paradigm Shift in Biology
Synthetic Biology Technology Overview
Enabling Technologies
DNA-Synthesis and DNA-Sequencing Cost Trends
DNA-Synthesis Technologies
Microfluidic Technologies
Next-Generation Sequencing Technologies
Gene Editing
Gene Drives
Bioinformatics Technologies
Biologic Components and Integrated Systems Technologies
Synthetic DNA
BioBrick Parts
Minimal Genomes and Chassis Organisms
Enabled Products
Pathway Engineering
Research and Development Applications
Synthetic Biology and the Microbiome
Synthetic Biology in Biofuels Feedstocks
Synthetic Biology Microbiome Initiatives
Current Governance and Regulations
U.S. Regulations
International Regulations
Chapter 5 Synthetic Biology Applications
Enabling Technologies Applications
Biologic Components and Integrated Systems Applications
Synthetic Genes
BioBrick Parts
Integrated Systems
Enabled Products Applications
Pharmaceuticals
Industrial Biotechnology Applications
Agricultural Applications
Data Storage Applications
Chapter 6 Synthetic Biology Industry
Investment in Synthetic Biology Industry
Industrial Biotechnology Value Chain
Industry Structural Forces
Products and Technology Life Cycle
Sequencing Instruments Industry
Long-Read Sequencing Industry
DNA Synthesis Industry
Oligos as Therapeutics
Gene Synthesis Workflow
Gene Synthesis Value Chain
Synthetic Gene Market Segments
Gene-Editing Industry
Synthetic Biology Organism Design and Foundries Industry
Software Industry
Agriculture Industry
Consumer Products Industry
Cosmetics and Skin Care Industry
Food and Beverage Industry
Healthcare Industry
Industrial Chemicals Industry
Cell-Free System Industry
Industry Acquisitions and Strategic Alliances
Chapter 7 Global Market for Synthetic Biology
Industry Growth-Driving Forces
DNA Read, Write and Edit Technologies
Growing Role of Designer Organisms
Speeding up of Commercialization Pathways
Growth in Synthetic Biology Foundries
Increasing Research and Development Investment by Pharma Companies
Global Market for Synthetic Biology by End-User Industry
Research Market
Healthcare Market
Industrial Chemicals Market
Agriculture Market
Consumer Market
Food and Beverage Market
Global Market for Synthetic Biology by Product Type
Enabling Products Market
Synthetic Biologic Components Market
Integrated Systems Market
Enabled Products Market
Geographic Markets
Synthetic Biology Products by Region
Enabling Products Market by Region
Core Products Market by Region
Enabled Products Market by Region
Chapter 8 Patents
Introduction
Foundational Patents
Synthetic Biology Patent Analysis
Sequencing-Related Patent Issues
Gene Editing-Related Patents
Gene Editing Patents: Sangamo Case Study
Chapter 9 Company Profiles
Key Market Players
AGILENT TECHNOLOGIES INC.
AMYRIS INC.
CODEXIS INC.
EUROFINS SCIENTIFIC
GENSCRIPT
GINKGO BIOWORKS
MERCK KGAA
NOVOZYMES A/S
THERMO FISHER SCIENTIFIC INC.
TWIST BIOSCIENCE
VIRIDOS
Other Players
20N LABS INC.
ABEONA THERAPEUTICS LLC
ACTIVE MOTIF
AEMETIS INC.
AGRIVIDA INC.
AJINOMOTO CO., INC.
ALGENUITY
AMBRX INC.
AMFORA INC.
ANSA BIOTECHNOLOGIES INC.
ANTHEIA INC.
ARBOR BIOTECHNOLOGIES INC.
ARCADIA BIOSCIENCES INC.
ARCTURUS THERAPEUTICS INC.
ARDRA BIO INC.
ARZEDA CORP.
ASTRAZENECA PLC
ATG BIOSYNTHETICS GMBH
ATUM
AVECIA
AZARGEN BIOTECHNOLOGIES PTY., LTD.
AZITRA INC.
BASF AG
BAYER AG
BEAM THERAPEUTICS INC.
BENCHLING
BENSON HILL BIOSYSTEMS INC.
BIO BASIC INC.
BIOGEN INC.
BIOMAX INFORMATICS AG
BIOMX LTD.
BIONEER CORP.
BIO S&T INC.
BIOSYNTIA APS
BLUEBIRD BIO INC.
BOLT THREADS INC.
BRISTOL-MYERS SQUIBB CO.
CALYSTA INC.
CALYXT INC.
CARGILL INC.
CARIBOU BIOSCIENCES INC.
CRISPR THERAPEUTICS
CASZYME
CATALOG TECHNOLOGIES, INC.
CELLECTIS SA
CENTRIENT PHARMACEUTICALS
CHAIN BIOTECHNOLOGY LTD.
CIBUS INC.
C-LECTA GMBH
CODAGENIX INC.
COLORIFIX LTD.
CORBION
CRONOS GROUP
CROWN LABORATORIES INC.
DANAHER CORP.
DEMURIS LTD.
DNA SCRIPT
DOVETAIL GENOMICS LLC
DOWDUPONT INC.
EDIGENE INC.
EDITAS MEDICINE INC.
ELIGO BIOSCIENCE SAS
ENDLESS WEST
ENEVOLV INC.
EPOCH LIFE SCIENCE INC.
EVONETIX
EVOLVA SA
EXXONMOBIL CORP.
G+FLAS LIFE SCIENCES INC.
GEA ENZYMES
GELTOR INC.
GENEMED SYNTHESIS INC.
GENERAY BIOTECH CO., LTD.
GENOMATICA
GENUS PLC
GEVO INC.
GILEAD SCIENCES INC.
GLAXOSMITHKLINE PLC
GLOBAL BIOENERGIES
GLOWEE- UNREASONABLE GROUP
GLYCOSBIO FOOD SCIENCES
GLYCOSYN LLC
GOODYEAR TIRE & RUBBER CO.
HELIXWORKS TECHNOLOGIES LTD.
HOMOLOGY MEDICINES INC.
HORIZON DISCOVERY GROUP PLC
HUVEPHARMA
ILLUMINA INC.
IMPOSSIBLE FOODS INC.
INDUSTRIAL MICROBES INC.
INGENZA LTD.
INOVIO PHARMACEUTICALS INC.
INSCRIPTA INC.
INTELLIA THERAPEUTICS INC.
INTERNATIONAL BUSINESS MACHINES
JOYN BIO
KANEKA CORP.
KWS SAAT SE
LABGENIUS LTD.
LANZATECH
LATTICE AUTOMATION INC.
LC SCIENCES
LCY CHEMICAL CORP.
LGC GROUP
LOCUS BIOSCIENCES
LOGICBIO THERAPEUTICS
LUMEN BIOSCIENCE
LYGOS INC.
MEISSA VACCINES, INC.
MICROSYNBIOTIX
MICROBYRE, INC.
MICROSOFT CORP.
MILIS BIO LTD.
MODERN MEADOW
MODULAR GENETICS INC.
MOLECULAR ASSEMBLIES INC.
MORPHOSYS AG
MOTIF INGREDIENTS
NEW ENGLAND BIOLABS
NOVARTIS PHARMA AG
NOVOME BIOTECHNOLOGIES INC.
NOVVI LLC
NUCELIS LLC
NUCLERA NUCLEICS LTD.
OMEGA BIO-TEK INC.
ORAGENICS INC.
OXFORD BIOMEDICA PLC
PAIRWISE PLANTS INC.
PFIZER INC.
PHIO PHARMACEUTICALS CORP.
PHYTOWELT GREEN TECHNOLOGIES GMBH
PIVOT BIO
POSEIDA THERAPEUTICS INC.
PRECISION BIOSCIENCES INC.
PROKARIUM HOLDINGS LTD.
PROMEGA CORP.
PTC THERAPEUTICS INC.
RECOMBINETICS INC.
ROQUETTE FRERES
ROYAL DSM NV
SANGAMO THERAPEUTICS INC.
SAREPTA THERAPEUTICS INC.
SCARAB GENOMICS LLC
SENTI BIOSCIENCES
SHINEGENE MOLECULAR BIO-TECHNOLOGIES INC.
SIGMA ALDRICH CORP.
SHERLOCK BIOSCIENCES
SILICOLIFE LDA.
SOCATI CORP.
SPIBER INC.
STRING BIO
SUGARLOGIX
SYNBIO TECHNOLOGIES INC.
SYNGENTA AG (CHEMCHINA)
SYNTHEGO CORP.
SYNLOGIC THERAPEUTICS
SYNTHACE LTD.
SYNTHETIC BIOLOGICS INC.
TAKARA BIO
TEPHA INC.
TESELAGEN BIOTECHNOLOGY INC.
TIERRA BIOSCIENCES
TOOLGEN
TRANSCRIPTIC INC.
TROPIC BIOSCIENCES U.K. LTD.
TRITON ALGAE INNOVATIONS LTD.
VEDANTA BIOSCIENCES
VERSALIS SPA
VERTEX PHARMACEUTICALS INC.
VIR BIOTECHNOLOGY INC.
XYPHOS BIOSCIENCES, INC.
YIELD10 BIOSCIENCES INC.
ZIOPHARM ONCOLOGY, INC.
ZYMERGEN
ZYMOCHEM INC.

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野の最新刊レポート

  • 本レポートと同分野の最新刊レポートはありません。

BCC Research社の分野での最新刊レポート

  • 最新刊レポートはありません。

本レポートと同じKEY WORD()の最新刊レポート

  • 本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問


BCC Research社はどのような調査会社ですか?


BCCリサーチ(BCC Research)は1971年に設立され、様々な業界経験を持つアナリストと編集者によりトップクラスの市場情報源を長年提供している調査会社です。   設立初期は先端材料とプラ... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/22 10:26

155.52 円

163.34 円

198.56 円

ページTOPに戻る